Researchers analyzed the neurological symptoms of 509 consecutive COVID-19 patients admitted to 10 Northwestern hospitals between March 5 and April 6.
Five study findings:
1. Overall, 82.3 percent of patients had neurological symptoms.
2. About 42 percent of patients had neurologic symptoms at COVID-19 onset, and 62 percent had symptoms during their hospitalization.
3. The most frequent neurological symptoms were:
- myalgias (muscle aches): 44.8 percent
- headaches: 37.7 percent
- encephalopathy (a general term describing damage or disease to the brain): 31.8 percent
- dizziness: 29.7 percent
- impaired taste: 15.9 percent
- loss of smell: 11.4 percent
4. While younger patients and those with severe COVID-19 were more likely to develop neurological symptoms overall, older patients were more likely to develop encephalopathy.
5. Encephalopathy also was linked to a three times longer hospital stay for COVID-19 patients and a roughly seven times higher risk of death within 30 days of hospitalization.
View the full study here.
More articles on patient safety & outcomes:
Dartmouth-Hitchcock performs 1,000th transplant
Black newborn mortality rate cut in half when cared by Black physicians
10 tips for preventing medication errors during COVID-19 surges
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.